drugset / Trial / NCT02766725

Thermosensitive Gels for the Vaginal Delivery of Sildenafil Citrate

NCT02766725

Phase 2/3 Completed 90 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study was to develop and characterize in situ thermosensitive gels for the vaginal administration of sildenafil as a potential treatment of the endometrial thinning that occurs as a result of the use of clomiphene citrate in induction of ovulation in women with World Health Organization type II EU gonadotrophic anovulation.

Timeline

Start
2015-01
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg Other

Indications